img

Global Aflibercept Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Aflibercept Drug Market Insights, Forecast to 2034

Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer.
Global Aflibercept Drug market is expected to reach to US$ 5841 million in 2024, with a positive growth of %, compared with US$ 5617 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Aflibercept Drug industry is evaluated to reach US$ 7305.9 million in 2029. The CAGR will be 3.8% during 2024 to 2029.
The Eylea market is primarily driven by the increasing prevalence of retinal diseases and the demand for effective treatments. Eylea (aflibercept) is a medication used to treat various eye conditions, including wet age-related macular degeneration (AMD) and diabetic macular edema. The growing aging population and the rise in chronic diseases like diabetes contribute to market growth. Moreover, advancements in ocular therapeutics and the demonstrated efficacy of Eylea in improving visual outcomes further propel adoption. However, challenges include managing the high cost of treatment and ensuring equitable access to care. Navigating the competitive landscape, optimizing treatment protocols, and addressing potential side effects are ongoing concerns. The market's success relies on continuous research to expand the indications for Eylea, collaborations between pharmaceutical manufacturers and ophthalmologists, and comprehensive patient education on the benefits and potential risks of treatment while addressing the evolving challenges associated with retinal disease management and treatment affordability.
Report Covers
This report presents an overview of global Aflibercept Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Aflibercept Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Regeneron
Bayer
Sanofi
Segment by Type
Prefilled Syring Package
Vial Package

Segment by Application


Eye Disease
Cancer

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Aflibercept Drug plant distribution, commercial date of Aflibercept Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Aflibercept Drug introduction, etc. Aflibercept Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Aflibercept Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Aflibercept Drug Product Introduction
1.2 Market by Type
1.2.1 Global Aflibercept Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Prefilled Syring Package
1.2.3 Vial Package
1.3 Market by Application
1.3.1 Global Aflibercept Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Eye Disease
1.3.3 Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Aflibercept Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Aflibercept Drug Revenue by Region
2.2.1 Global Aflibercept Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Aflibercept Drug Revenue by Region (2018-2024)
2.2.3 Global Aflibercept Drug Revenue by Region (2024-2029)
2.2.4 Global Aflibercept Drug Revenue Market Share by Region (2018-2029)
2.3 Global Aflibercept Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Aflibercept Drug Sales by Region
2.4.1 Global Aflibercept Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Aflibercept Drug Sales by Region (2018-2024)
2.4.3 Global Aflibercept Drug Sales by Region (2024-2029)
2.4.4 Global Aflibercept Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Aflibercept Drug Sales by Manufacturers
3.1.1 Global Aflibercept Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Aflibercept Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Aflibercept Drug in 2022
3.2 Global Aflibercept Drug Revenue by Manufacturers
3.2.1 Global Aflibercept Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Aflibercept Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Aflibercept Drug Revenue in 2022
3.3 Global Key Players of Aflibercept Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Aflibercept Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Aflibercept Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Aflibercept Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Aflibercept Drug, Product Offered and Application
3.8 Global Key Manufacturers of Aflibercept Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Aflibercept Drug Sales by Type
4.1.1 Global Aflibercept Drug Historical Sales by Type (2018-2024)
4.1.2 Global Aflibercept Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Aflibercept Drug Sales Market Share by Type (2018-2029)
4.2 Global Aflibercept Drug Revenue by Type
4.2.1 Global Aflibercept Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Aflibercept Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Aflibercept Drug Revenue Market Share by Type (2018-2029)
4.3 Global Aflibercept Drug Price by Type
4.3.1 Global Aflibercept Drug Price by Type (2018-2024)
4.3.2 Global Aflibercept Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Aflibercept Drug Sales by Application
5.1.1 Global Aflibercept Drug Historical Sales by Application (2018-2024)
5.1.2 Global Aflibercept Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Aflibercept Drug Sales Market Share by Application (2018-2029)
5.2 Global Aflibercept Drug Revenue by Application
5.2.1 Global Aflibercept Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Aflibercept Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Aflibercept Drug Revenue Market Share by Application (2018-2029)
5.3 Global Aflibercept Drug Price by Application
5.3.1 Global Aflibercept Drug Price by Application (2018-2024)
5.3.2 Global Aflibercept Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Aflibercept Drug Market Size by Type
6.1.1 US & Canada Aflibercept Drug Sales by Type (2018-2029)
6.1.2 US & Canada Aflibercept Drug Revenue by Type (2018-2029)
6.2 US & Canada Aflibercept Drug Market Size by Application
6.2.1 US & Canada Aflibercept Drug Sales by Application (2018-2029)
6.2.2 US & Canada Aflibercept Drug Revenue by Application (2018-2029)
6.3 US & Canada Aflibercept Drug Market Size by Country
6.3.1 US & Canada Aflibercept Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Aflibercept Drug Sales by Country (2018-2029)
6.3.3 US & Canada Aflibercept Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Aflibercept Drug Market Size by Type
7.1.1 Europe Aflibercept Drug Sales by Type (2018-2029)
7.1.2 Europe Aflibercept Drug Revenue by Type (2018-2029)
7.2 Europe Aflibercept Drug Market Size by Application
7.2.1 Europe Aflibercept Drug Sales by Application (2018-2029)
7.2.2 Europe Aflibercept Drug Revenue by Application (2018-2029)
7.3 Europe Aflibercept Drug Market Size by Country
7.3.1 Europe Aflibercept Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Aflibercept Drug Sales by Country (2018-2029)
7.3.3 Europe Aflibercept Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Aflibercept Drug Market Size
8.1.1 China Aflibercept Drug Sales (2018-2029)
8.1.2 China Aflibercept Drug Revenue (2018-2029)
8.2 China Aflibercept Drug Market Size by Application
8.2.1 China Aflibercept Drug Sales by Application (2018-2029)
8.2.2 China Aflibercept Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Aflibercept Drug Market Size by Type
9.1.1 Asia Aflibercept Drug Sales by Type (2018-2029)
9.1.2 Asia Aflibercept Drug Revenue by Type (2018-2029)
9.2 Asia Aflibercept Drug Market Size by Application
9.2.1 Asia Aflibercept Drug Sales by Application (2018-2029)
9.2.2 Asia Aflibercept Drug Revenue by Application (2018-2029)
9.3 Asia Aflibercept Drug Sales by Region
9.3.1 Asia Aflibercept Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Aflibercept Drug Revenue by Region (2018-2029)
9.3.3 Asia Aflibercept Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Aflibercept Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Aflibercept Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Aflibercept Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Aflibercept Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Aflibercept Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Aflibercept Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Aflibercept Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Aflibercept Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Aflibercept Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Aflibercept Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Regeneron
11.1.1 Regeneron Company Information
11.1.2 Regeneron Overview
11.1.3 Regeneron Aflibercept Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Regeneron Aflibercept Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Regeneron Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Aflibercept Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Bayer Aflibercept Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Aflibercept Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sanofi Aflibercept Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Aflibercept Drug Industry Chain Analysis
12.2 Aflibercept Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Aflibercept Drug Production Mode & Process
12.4 Aflibercept Drug Sales and Marketing
12.4.1 Aflibercept Drug Sales Channels
12.4.2 Aflibercept Drug Distributors
12.5 Aflibercept Drug Customers
13 Market Dynamics
13.1 Aflibercept Drug Industry Trends
13.2 Aflibercept Drug Market Drivers
13.3 Aflibercept Drug Market Challenges
13.4 Aflibercept Drug Market Restraints
14 Key Findings in The Global Aflibercept Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Aflibercept Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Prefilled Syring Package
Table 3. Major Manufacturers of Vial Package
Table 4. Global Aflibercept Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Aflibercept Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Aflibercept Drug Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Aflibercept Drug Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Aflibercept Drug Revenue Market Share by Region (2018-2024)
Table 9. Global Aflibercept Drug Revenue Market Share by Region (2024-2029)
Table 10. Global Aflibercept Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Aflibercept Drug Sales by Region (2018-2024) & (K Units)
Table 12. Global Aflibercept Drug Sales by Region (2024-2029) & (K Units)
Table 13. Global Aflibercept Drug Sales Market Share by Region (2018-2024)
Table 14. Global Aflibercept Drug Sales Market Share by Region (2024-2029)
Table 15. Global Aflibercept Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Aflibercept Drug Sales Share by Manufacturers (2018-2024)
Table 17. Global Aflibercept Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Aflibercept Drug Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Aflibercept Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Aflibercept Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Aflibercept Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Aflibercept Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aflibercept Drug as of 2022)
Table 23. Global Key Manufacturers of Aflibercept Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Aflibercept Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Aflibercept Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Aflibercept Drug Sales by Type (2018-2024) & (K Units)
Table 28. Global Aflibercept Drug Sales by Type (2024-2029) & (K Units)
Table 29. Global Aflibercept Drug Sales Share by Type (2018-2024)
Table 30. Global Aflibercept Drug Sales Share by Type (2024-2029)
Table 31. Global Aflibercept Drug Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Aflibercept Drug Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Aflibercept Drug Revenue Share by Type (2018-2024)
Table 34. Global Aflibercept Drug Revenue Share by Type (2024-2029)
Table 35. Aflibercept Drug Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Aflibercept Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Aflibercept Drug Sales by Application (2018-2024) & (K Units)
Table 38. Global Aflibercept Drug Sales by Application (2024-2029) & (K Units)
Table 39. Global Aflibercept Drug Sales Share by Application (2018-2024)
Table 40. Global Aflibercept Drug Sales Share by Application (2024-2029)
Table 41. Global Aflibercept Drug Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Aflibercept Drug Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Aflibercept Drug Revenue Share by Application (2018-2024)
Table 44. Global Aflibercept Drug Revenue Share by Application (2024-2029)
Table 45. Aflibercept Drug Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Aflibercept Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Aflibercept Drug Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Aflibercept Drug Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Aflibercept Drug Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Aflibercept Drug Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Aflibercept Drug Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Aflibercept Drug Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Aflibercept Drug Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Aflibercept Drug Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Aflibercept Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Aflibercept Drug Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Aflibercept Drug Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Aflibercept Drug Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Aflibercept Drug Sales by Country (2024-2029) & (K Units)
Table 60. Europe Aflibercept Drug Sales by Type (2018-2024) & (K Units)
Table 61. Europe Aflibercept Drug Sales by Type (2024-2029) & (K Units)
Table 62. Europe Aflibercept Drug Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Aflibercept Drug Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Aflibercept Drug Sales by Application (2018-2024) & (K Units)
Table 65. Europe Aflibercept Drug Sales by Application (2024-2029) & (K Units)
Table 66. Europe Aflibercept Drug Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Aflibercept Drug Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Aflibercept Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Aflibercept Drug Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Aflibercept Drug Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Aflibercept Drug Sales by Country (2018-2024) & (K Units)
Table 72. Europe Aflibercept Drug Sales by Country (2024-2029) & (K Units)
Table 73. China Aflibercept Drug Sales by Type (2018-2024) & (K Units)
Table 74. China Aflibercept Drug Sales by Type (2024-2029) & (K Units)
Table 75. China Aflibercept Drug Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Aflibercept Drug Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Aflibercept Drug Sales by Application (2018-2024) & (K Units)
Table 78. China Aflibercept Drug Sales by Application (2024-2029) & (K Units)
Table 79. China Aflibercept Drug Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Aflibercept Drug Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Aflibercept Drug Sales by Type (2018-2024) & (K Units)
Table 82. Asia Aflibercept Drug Sales by Type (2024-2029) & (K Units)
Table 83. Asia Aflibercept Drug Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Aflibercept Drug Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Aflibercept Drug Sales by Application (2018-2024) & (K Units)
Table 86. Asia Aflibercept Drug Sales by Application (2024-2029) & (K Units)
Table 87. Asia Aflibercept Drug Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Aflibercept Drug Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Aflibercept Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Aflibercept Drug Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Aflibercept Drug Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Aflibercept Drug Sales by Region (2018-2024) & (K Units)
Table 93. Asia Aflibercept Drug Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Aflibercept Drug Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Aflibercept Drug Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Aflibercept Drug Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Aflibercept Drug Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Aflibercept Drug Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Aflibercept Drug Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Aflibercept Drug Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Aflibercept Drug Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Aflibercept Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Aflibercept Drug Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Aflibercept Drug Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Aflibercept Drug Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Aflibercept Drug Sales by Country (2024-2029) & (K Units)
Table 107. Regeneron Company Information
Table 108. Regeneron Description and Major Businesses
Table 109. Regeneron Aflibercept Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Regeneron Aflibercept Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Regeneron Recent Developments
Table 112. Bayer Company Information
Table 113. Bayer Description and Major Businesses
Table 114. Bayer Aflibercept Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Bayer Aflibercept Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Bayer Recent Developments
Table 117. Sanofi Company Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi Aflibercept Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi Aflibercept Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Recent Developments
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Aflibercept Drug Distributors List
Table 125. Aflibercept Drug Customers List
Table 126. Aflibercept Drug Market Trends
Table 127. Aflibercept Drug Market Drivers
Table 128. Aflibercept Drug Market Challenges
Table 129. Aflibercept Drug Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Aflibercept Drug Product Picture
Figure 2. Global Aflibercept Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Aflibercept Drug Market Share by Type in 2022 & 2029
Figure 4. Prefilled Syring Package Product Picture
Figure 5. Vial Package Product Picture
Figure 6. Global Aflibercept Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Aflibercept Drug Market Share by Application in 2022 & 2029
Figure 8. Eye Disease
Figure 9. Cancer
Figure 10. Aflibercept Drug Report Years Considered
Figure 11. Global Aflibercept Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Aflibercept Drug Revenue 2018-2029 (US$ Million)
Figure 13. Global Aflibercept Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Aflibercept Drug Revenue Market Share by Region (2018-2029)
Figure 15. Global Aflibercept Drug Sales 2018-2029 ((K Units)
Figure 16. Global Aflibercept Drug Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Aflibercept Drug Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Aflibercept Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Aflibercept Drug Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Aflibercept Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Aflibercept Drug Sales YoY (2018-2029) & (K Units)
Figure 22. China Aflibercept Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Aflibercept Drug Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Aflibercept Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Aflibercept Drug Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Aflibercept Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Aflibercept Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Aflibercept Drug in the World: Market Share by Aflibercept Drug Revenue in 2022
Figure 29. Global Aflibercept Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Aflibercept Drug Sales Market Share by Type (2018-2029)
Figure 31. Global Aflibercept Drug Revenue Market Share by Type (2018-2029)
Figure 32. Global Aflibercept Drug Sales Market Share by Application (2018-2029)
Figure 33. Global Aflibercept Drug Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Aflibercept Drug Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Aflibercept Drug Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Aflibercept Drug Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Aflibercept Drug Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Aflibercept Drug Revenue Share by Country (2018-2029)
Figure 39. US & Canada Aflibercept Drug Sales Share by Country (2018-2029)
Figure 40. U.S. Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Aflibercept Drug Sales Market Share by Type (2018-2029)
Figure 43. Europe Aflibercept Drug Revenue Market Share by Type (2018-2029)
Figure 44. Europe Aflibercept Drug Sales Market Share by Application (2018-2029)
Figure 45. Europe Aflibercept Drug Revenue Market Share by Application (2018-2029)
Figure 46. Europe Aflibercept Drug Revenue Share by Country (2018-2029)
Figure 47. Europe Aflibercept Drug Sales Share by Country (2018-2029)
Figure 48. Germany Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 49. France Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 53. China Aflibercept Drug Sales Market Share by Type (2018-2029)
Figure 54. China Aflibercept Drug Revenue Market Share by Type (2018-2029)
Figure 55. China Aflibercept Drug Sales Market Share by Application (2018-2029)
Figure 56. China Aflibercept Drug Revenue Market Share by Application (2018-2029)
Figure 57. Asia Aflibercept Drug Sales Market Share by Type (2018-2029)
Figure 58. Asia Aflibercept Drug Revenue Market Share by Type (2018-2029)
Figure 59. Asia Aflibercept Drug Sales Market Share by Application (2018-2029)
Figure 60. Asia Aflibercept Drug Revenue Market Share by Application (2018-2029)
Figure 61. Asia Aflibercept Drug Revenue Share by Region (2018-2029)
Figure 62. Asia Aflibercept Drug Sales Share by Region (2018-2029)
Figure 63. Japan Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 67. India Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Aflibercept Drug Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Aflibercept Drug Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Aflibercept Drug Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Aflibercept Drug Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Aflibercept Drug Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Aflibercept Drug Sales Share by Country (2018-2029)
Figure 74. Brazil Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Aflibercept Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Aflibercept Drug Value Chain
Figure 80. Aflibercept Drug Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries